Alglucerase Completed Phase 2 Trials for Gaucher's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00001416Bone Response to Enzyme Replacement in Gaucher's Disease